Sen. Tammy Baldwin, D-Wis., and two other Senators are questioning price increases for a drug that treats glaucoma and a genetic disease that causes temporary muscle weakness and paralysis.
To access this content, you must purchase a Premium membership, or log in if you are a member.
Support Our Advertisers
STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.
Subscribe here for a FREE 14 day trial of our daily news roundup.